Samsung Biologics inks manufacturing deal with GreenLight
SEOUL– South Korean pharmaceutical firm Samsung Biologics Co. said Thursday it has signed a supply agreement with U.S.-based biotech company GreenLight Biosciences. Under the contract manufacturing organization (CMO) agreement, Samsung Biologics will manufacture drug substances for GreenLight’s mRNA COVID-19 vaccine candidate. Samsung Biologics will manufacture drug substances of the mRNA COVID-19 vaccine candidate for … Read more